Becton Dickinson And Company (BDX) closed at $211.88 on November 6, 2026, down 0.8% from the previous close, on volume of 1,938,943 shares (30-day average 1,725,384).
Data as of November 6, 2026.
6-Nov-2026
Bank of America Securities Remains a Hold on Becton Dickinson (BDX)
TipRanks (Sat, 7-Nov 12:36 AM ET)
Dividend Roundup: Apple, 3M, Cohen & Steers, ConocoPhillips, and more
Seeking Alpha News (Fri, 6-Nov 8:00 AM ET)
Barclays Keeps Their Sell Rating on Becton Dickinson (BDX)
TipRanks (Fri, 6-Nov 4:07 AM ET)
Becton, Dickinson declares $1.06 dividend
Seeking Alpha News (Fri, 6-Nov 3:00 AM ET)
Becton, Dickinson Earnings Call Highlights Growth Amid Headwinds
TipRanks (Thu, 5-Nov 7:26 PM ET)
BDX highlights cash-flow surge as fiscal 2027 adjusted EPS guidance moves to $13.10–$13.30
Market Chameleon (Thu, 5-Nov 2:54 AM ET)
Becton, Dickinson falls after in-line guidance for FY27
Seeking Alpha News (Thu, 5-Nov 7:24 AM ET)
Becton, Dickinson beats top-line and bottom-line estimates; initiates FY2027 outlook
Seeking Alpha News (Thu, 5-Nov 6:33 AM ET)
BD Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
PRNewswire (Thu, 5-Nov 6:30 AM ET)
Becton, Dickinson lifts dividend by 1% to $1.06/share
Seeking Alpha News (Thu, 5-Nov 6:28 AM ET)
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Becton Dickinson And Company trades on the NYSE stock market under the symbol BDX.
As of November 6, 2026, BDX stock price declined to $211.88 with 1,938,943 million shares trading.
BDX has a beta of 0.17, meaning it tends to be less sensitive to market movements. BDX has a correlation of 0.01 to the broad based SPY ETF.
BDX has a market cap of $60.27 billion. This is considered a Large Cap stock.
Last quarter Becton Dickinson And Company reported $5 billion in Revenue and $4.15 earnings per share. This beat revenue expectation by $159 million and exceeded earnings estimates by $.08.
In the last 3 years, BDX traded as high as $259.92 and as low as $140.11.
The top ETF exchange traded funds that BDX belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
BDX has outperformed the market in the last year with a price return of +47.7% while the SPY ETF gained +9.6%. BDX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +24.8% and +5.7%, respectively, while the SPY returned -4.2% and -3.8%, respectively.
BDX support price is $210.59 and resistance is $216.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDX shares will trade within this expected range on the day.
